The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear¥372.19Fair value¥1,728.05Bull¥3,246.41
FairClose
52-week traded range
52W low ¥1,083.0052W high ¥1,370.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
KNC Laboratories Co.,Ltd. closed at ¥1,248.00, 27.8% below the consensus fair value of ¥1,728.05 drawn from 9 valuation models.
Financial DNA score 54/100 — Good. P/E of 12.6x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
¥1,513.86
+21.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=4.5%, r=10%, tg=3%, n=10yr
Graham Number
¥2,007.41
+60.8%
√(22.5 × EPS × BVPS)
EPS=99.02, BVPS=1808.7
P/E Fair Value
¥1,980.40
+58.7%
EPS × 20x (sector P/E)
EPS=99.02, Sector P/E=20x
Peter Lynch (PEG)
¥441.63
-64.6%
EPS × Growth% (PEG = 1 is fair)
EPS=99.02, g=4.5%
EV/EBITDA
¥3,246.41
+160.1%
(EBITDA × 12.2x − Net Debt) ÷ Shares
EBITDA=2.26B
Dividend Discount (DDM)
¥621.24
-50.2%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=32.95, r=10%, g=4.5%
Book Value (P/B)
¥372.19
-70.2%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=1808.7, ROE=5.6%, g=4.5%, r=10%
Reverse DCF
¥1,248.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 0.9% | Historical: 4.5%
Margin of Safety
¥1,375.42
+10.2%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=1833.89, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.